Search results for "PN"

showing 10 items of 2154 documents

Is the implementation of a microbiological surveillance screening beneficial in a neonatal intensive care unit?

2015

s of the 51st Workshop for Pediatric Research 51st Workshop for Pediatric Research Gottingen, Germany 16-17 April 2015 This supplement has not been sponsored. Meeting abstracts Background and aims Bacteria that cause nosocomial infections have often been found to colonize the patient's skin, respiratory tract or gastrointestinal tract previously. In 2012 and 2013, the German Commission for Hospital Hygiene and Infectious Disease Prevention recommended a microbiological screening of infants on neonatal intensive care units. Multidrug-resistant bacteria (MDR) that should be considered in empiric antibiotic therapy, bacteria that cause invasive infections and bacteria that may elicit epidemic …

medicine.medical_specialtyNeonatal intensive care unitbiologymedicine.drug_classbusiness.industryKlebsiella pneumoniaeeducationAntibioticsEnterobacterbiology.organism_classificationInfectious disease (medical specialty)Intensive careMeeting AbstractEpidemiologymedicineIntensive care medicinebusinessPathogenMolecular and Cellular Pediatrics
researchProduct

Swallowing impairment in neurologic disorders: The role of videofluorographic swallowing study

2018

Patients with neurologic diseases almost inevitably develop various degrees of swallowing disorders during their life. Dysphagia is one of the main negative prognostic factors in this class of patients, leading to severe morbidity (i.e. aspiration pneumonia, dehydration, malnutrition, and life quality deterioration) and to a noticeable increase in public health spending. Videofluorographic swallowing study is considered the gold standard technique for swallowing impairment assessment. It is aimed at early identification of the risk of aspiration, definition of the kind and grade of dysphagia, and an indication to suspend oral nutrition and adopt other feeding strategies, and define when the…

medicine.medical_specialtyNeurologic diseaseRadiology Nuclear Medicine and ImagingdysphagiaAspiration pneumonia030218 nuclear medicine & medical imagingVideofluorography03 medical and health sciences0302 clinical medicineSwallowingQuality of lifeotorhinolaryngologic diseasesMedicineIntensive care medicineReview Paperbusiness.industrySwallowing DisordersPublic healthGold standardDysphagiaSwallowingmedicine.diseaseDysphagiaMalnutritionneurologic diseasesmedicine.symptomvideofluorographybusinessswallowing030217 neurology & neurosurgery
researchProduct

Management of obstructive sleep apnea in Europe.

2011

Objectives: In Europe, the services provided for the investigation and management of obstructive sleep apnoea (OSA) varies from country to country. The aim of this questionnaire-based study was to investigate the current status of diagnostic pathways and therapeutic approaches applied in the treatment of OSA in Europe, qualification requirements of physicians involved in diagnosis and treatment of OSA, and reimbursement of these services. Methods: Two questionnaires were sent to 39 physicians in 22 countries in Europe. In order to standardize the responses, the questionnaire was accompanied by an example. Results: Sleep centers from 21 countries (38 physicians) participated. A broad consist…

medicine.medical_specialtyNeurologyCertificationInternationalityReferralmedicine.medical_treatmentPolysomnographyPolysomnographySettore MED/10 - Malattie Dell'Apparato RespiratorioSurveys and QuestionnairesPositive airway pressuremedicineHumansContinuous positive airway pressureIntensive care medicineReimbursementSleep Apnea ObstructivePublic health services sleep apnea sleep disordered breathing OSA management OSA therapy OSA reibursement OSA treatmentmedicine.diagnostic_testContinuous Positive Airway Pressurebusiness.industrySleep apneaProfessional PracticeMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREGeneral Medicinemedicine.diseaserespiratory tract diseasesObstructive sleep apneaEuropeHealth Care SurveysPublic health servicesSleep apnea Sleep disordered breathing OSA management OSA therapyOSA reimbursement OSA treatmentMedicineHuman medicinebusinessSleep medicine
researchProduct

Post-acute COVID-19 neurological syndrome: A new medical challenge

2021

In December 2019, in Wuhan (China), a highly pathogenic coronavirus, named SARS-CoV-2, dramatically emerged. This new virus, which causes severe pneumonia, is rapidly spreading around the world, hence it provoked the COVID-19 pandemic. This emergency launched by SARS-CoV-2 also had, and still has, devastating socio-economic aspects. Assessing the impact of COVID-19 on vulnerable groups of people is crucial for the adaptation of governments’ responses. Growing scientific evidence suggests that it is essential to keep the attention on people after acute SARS-CoV-2 infection; indeed, some clinical manifestations are frequently present even after recovery. There is consensus on the need to defi…

medicine.medical_specialtyNeurologyCoronavirus disease 2019 (COVID-19)Brain damage COVID-19 Neurology Post-scute COVID-19 neurological syndrome SARS-CoV-2Brain damageReviewScientific evidence03 medical and health sciences0302 clinical medicinePandemicmedicine030212 general & internal medicineIntensive care medicineStrokebusiness.industrySARS-CoV-2neurologyRCOVID-19General Medicinebrain damagemedicine.diseasepost-scute COVID-19 neurological syndromeDeliriumMedicinemedicine.symptombusinessPneumonia (non-human)030217 neurology & neurosurgery
researchProduct

Technique and value of gas and pantopaque cisternography in the diagnosis of cerebello-pontine angle tumours

1971

The techniques of gas and Pantopaque cisternography are described, as well as the various advantages and disadventages of these methods. Patients without neurological signs in whom a small tumour is suspected in the region of the cerebellopontine angle should be examined with Pantopaque. The examination can be carried out as an outpatient procedure. If definite neurological signs are present, gas cisternography is preferable in order to demonstrate secondary displacements of the ventricular system as well as the tumour itself.

medicine.medical_specialtyNeurologymedicine.medical_treatmentContrast MediaCerebellopontine AngleVentricular systemSubarachnoid SpaceVestibulocochlear nervePeripheral Nervous System NeoplasmsMethodsmedicineHumansRadiology Nuclear Medicine and imagingPneumoencephalographyTrigeminal NerveNeuroradiologyBrain NeoplasmsTomography X-Raybusiness.industryVestibulocochlear NerveCerebellopontine anglemedicine.diseasemedicine.anatomical_structureArachnoiditisNeurology (clinical)RadiologySubarachnoid spaceArachnoiditisPneumoencephalographyCardiology and Cardiovascular MedicinebusinessNeurilemmomaNeuroradiology
researchProduct

Placebo and Nocebo Effects Across Symptoms: From Pain to Fatigue, Dyspnea, Nausea, and Itch

2019

Contains fulltext : 208540.pdf (Publisher’s version ) (Open Access) Placebo and nocebo effects are, respectively, the helpful and harmful treatment effects that do not arise from active treatment components. These effects have thus far been researched most often in pain. It is not yet clear to what extent these findings from pain can be generalized to other somatic symptoms. This review investigates placebo and nocebo effects in four other highly prevalent symptoms: dyspnea, fatigue, nausea, and itch. The role of learning mechanisms (verbal suggestions, conditioning) in placebo and nocebo effects on various outcomes (self-reported, behavioral, and physiological) of these different somatic s…

medicine.medical_specialtyNoceboNausealcsh:RC435-571Reviewplacebo and nocebo effectsPlacebo03 medical and health sciences0302 clinical medicinesuggestionconditioninglcsh:PsychiatryHeart ratemedicinepainitchLung functionPsychiatrybusiness.industrydyspneanausea030227 psychiatry3. Good healthNocebo EffectPsychiatry and Mental healthPhysical therapyInflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5]fatigueActive treatmentmedicine.symptombusiness030217 neurology & neurosurgery
researchProduct

Sleep apnea and its role in transportation safety

2017

Obstructive sleep apnea (OSA) is a main cause of excessive daytime sleepiness and increases the risk for driving accidents, which can be normalized by treatment with continuous positive airway pressure ventilation. Since it is estimated that OSA is not diagnosed in about 80% of cases, recognition of patients at risk for driving accidents is a problem from both medical and societal points of view. Strategies to screen and identify subjects at high risk for driving accidents are under study in order to improve safety on the road, especially for commercial drivers, who show a high prevalence of OSA.

medicine.medical_specialtyObstructive Sleep Apneamedicine.medical_treatmentTransportation safetyExcessive daytime sleepinessReviewSettore MED/10 - Malattie Dell'Apparato RespiratorioGeneral Biochemistry Genetics and Molecular Biologylaw.invention03 medical and health sciences0302 clinical medicinelawCPAPAnesthesiologyDriving accidentmedicineContinuous positive airway pressureGeneral Pharmacology Toxicology and PharmaceuticsOpen peer reviewGeneral Immunology and Microbiologydriving accidentsSleep apneaArticlesGeneral MedicineSleep disordersmedicine.diseaserespiratory tract diseasesObstructive sleep apnea030228 respiratory systemEmergency medicineVentilation (architecture)medicine.symptom030217 neurology & neurosurgery
researchProduct

Correlation between Polysomnographic Parameters and Tridimensional Changes in the Upper Airway of Obstructive Sleep Apnea Patients Treated with Mandi…

2021

Background. The effectiveness of mandibular advancement devices has been solidly demonstrated in the past. They are considered a valid alternative treatment to continuous positive airway pressure for patients with obstructive sleep apnea. Nevertheless, the relationship between polysomnographic parameters and the increase in the volume of the upper airway in patients with obstructive sleep apnea syndrome has not been clearly established so far. This study aimed to determine the impact of these oral appliances upon the volume of the airway after the device titration phase and correlate it with the degree of mandibular advancement and the improvement of polysomnographic parameters. Methods. Al…

medicine.medical_specialtyOral appliancemedicine.medical_treatmentobstructive sleep apnea syndromePolysomnographyArticlesleep disordered breathingInternal medicinemedicineContinuous positive airway pressureairway obstructionoral appliancemedicine.diagnostic_testbusiness.industryRGeneral MedicineAirway obstructionmedicine.diseaserespiratory tract diseasesObstructive sleep apneamandibular advancement deviceApnea–hypopnea indexCardiologyMedicineAirwaybusinessHypopneasnoringJournal of Clinical Medicine
researchProduct

Mepolizumab for eosinophilic chronic obstructive pulmonary disease

2017

BACKGROUNDPatients with chronic obstructive pulmonary disease (COPD) with an eosinophilic phenotype may benefit from treatment with mepolizumab, a monoclonal antibody directed against interleukin-5.METHODSWe performed two phase 3, randomized, placebo-controlled, double-blind, parallel-group trials comparing mepolizumab (100 mg in METREX, 100 or 300 mg in METREO) with placebo, given as a subcutaneous injection every 4 weeks for 52 weeks in patients with COPD who had a history of moderate or severe exacerbations while taking inhaled glucocorticoid-based triple maintenance therapy. In METREX, unselected patients in the modified intention-to-treat population with an eosinophilic phenotype were …

medicine.medical_specialtyPARALLEL-GROUPPopulationPlacebo-controlled studyPNEUMONIA RISKPlaceboPLACEBO-CONTROLLED TRIALGastroenterology03 medical and health sciencesDOUBLE-BLIND0302 clinical medicineMaintenance therapyInternal medicineEosinophilicmedicineINHALED FLUTICASONE FUROATE030212 general & internal medicineeducationCOPDeducation.field_of_studyIntention-to-treat analysisCOPD ASSESSMENT TESTSPUTUM EOSINOPHILIAbusiness.industryGeneral MedicineRANDOMIZED CONTROLLED-TRIALBLOOD EOSINOPHILSmedicine.diseaseSECONDARY ANALYSIS030228 respiratory systemImmunologybusinessMepolizumabmedicine.drug
researchProduct

P343 Procalcitonin role in the management of lower respiratory tract infections in preschool children

2017

Introduction One of the major advantage of procalcitonin compared to other parameters is its highly and early increase in response to bacterial infection. The increased procalcitonin levels can be observed 3 to 6 hours after infectious challenge. It is a parameter that made a significant contribution to the clinical diagnosis, severity of infection and in the same time procalcitonin kinetics cand be used to assess the effectiveness of treatment. Methods A single- centre observational study consecutively enrolled 70 preschool children with lower respiratory tract infections who were hospitalised in Paediatric Clinic Hospital of Sibiu between January 2013 and January 2017. Procalcitonin, were…

medicine.medical_specialtyPaediatric clinicRespiratory tract infectionsmedicine.drug_classbusiness.industryAntibioticsBronchopneumoniamedicine.diseaseProcalcitoninClinical diagnosisInternal medicinemedicineObservational studybusinessIntensive care medicineHospital stayPosters
researchProduct